Global Central Nervous System Biomarker Market to Grow at 10.49 % of CAGR During 2017 to 2025
“According to a new market research report published by Inkwood Research, The central nervous system market is anticipated to grow from $ 3587 million in 2016 to $8756 million by 2025, at a CAGR of 10.49% between 2017 and 2025.“
Browse 19 market data Tables and 36 Figures spread through 158 Pages and in-depth TOC on “central nervous system Market Forecast 2017-2025.”
Increasing usage of genomics; metabolomics; proteomics; and bioinformatics, funding by the framework programs for research and development of technology, Obesity, escalation in Public-private corporation, Upsurge in biomarker market due to FDA supports, innovations and technological advancement in biomarker market, Rise in real per capita healthcare are boosting the growth of global central nervous system market.
Increasing prevalence of chronic diseases attributed towards the growth of the drug discovery and development application.
Due to the increasing issues related to the central nervous system with the rising need for accurate identification of diseases and proper diagnosis the drug discovery and development segment is growing at a significant rate. Encouragement by the U.S. FDA for the integration of biomarkers in the field of drug developments and their appropriate usage in clinical practice has enlarged the scope for the biomarkers in this segment.
Obesity has become a major health issue
In modern-day environment and availability of low priced high-calorie food is leading to gain of weight among people which is thereby causing diseases like diabetes and problems of blood pressure. According to NCBI, the change in lifestyle which involves lack of physical activity, consumption of diets rich in calories is leading to obesity and overweight which is then leading to life threating diseases.
North America withstand to be the leader in the global CNS biomarker market
The North America region is expected to lead the Central Nervous System (CNS) biomarker market and is also anticipated to possess colossal share by the end of the forecasting years. The major reason for this growth is the rising fatal diseases like cardiovascular diseases, Alzheimer’s, schizophrenia, etc. The U.S is the leading country in the North America region, majorly due to the early development of technologies, evolving R & D in life science research and rising aging population.
The established players in the global Central nervous system market are Acumen Pharmaceuticals INC, Alseres Pharmaceuticals INC, Avacta group plc, Avid radiopharmaceuticals INC, Banyan Biomarkers, Diagenic ASA, Ekf diagnostics, Exonhit therapeutics, Proteome Sciences, and Thermo Fisher Scientific.
The central nervous system biomarker market report provides competitive landscapes, market drivers, trends, restraints, opportunities and challenges in this market. The report estimates the current size and the future growth potential of the market across diverse applications, technologies, verticals, types, and regions. The outlook of the report additionally comprises of mergers and acquisitions, strategies, product portfolios, agreements, partnerships and collaborations amongst the key players.
About Inkwood Research
Inkwood Research specializes in syndicated & customized research reports and consulting services.
Market intelligence studies with relevant fact-based research are customized across industry verticals including technology, automotive, chemicals, materials, healthcare, and energy with real comprehension acknowledging the business environments. Our geographical analysis comprises of North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.
Tel : +1 857-302-4704